These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10838494)
1. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Okusaka T; Okada S; Ueno H; Ikeda M; Yoshimori M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Iwata R; Furukawa H; Moriyama N; Sakamoto M; Hirohashi S Oncology; 2000 May; 58(4):293-9. PubMed ID: 10838494 [TBL] [Abstract][Full Text] [Related]
2. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma]. Takekoshi H; Oyama R Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the therapeutic effect of TAE on primary liver cancer. Yamada T; Makita F; Takehara K; Saitou S; Satou K; Endou K; Shimoda R; Matsuzaki Y; Matsumoto T; Yuasa K Cancer Chemother Pharmacol; 1994; 33 Suppl():S55-9. PubMed ID: 7511068 [TBL] [Abstract][Full Text] [Related]
4. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI]. Shimizu T; Endou H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693 [TBL] [Abstract][Full Text] [Related]
5. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919 [TBL] [Abstract][Full Text] [Related]
6. Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma. Khan KN; Nakata K; Kusumoto Y; Nakao K; Kato Y; Nagataki S J Gastroenterol Hepatol; 1998 Feb; 13(2):192-6. PubMed ID: 10221823 [TBL] [Abstract][Full Text] [Related]
7. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis. Kishi K; Sonomura T; Mitsuzane K; Nishida N; Kimura M; Satoh M; Yamada R; Kodama N; Kinoshita M; Tanaka H Radiat Med; 1992; 10(5):189-95. PubMed ID: 1279748 [TBL] [Abstract][Full Text] [Related]
8. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence. Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681 [TBL] [Abstract][Full Text] [Related]
9. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases. Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920 [TBL] [Abstract][Full Text] [Related]
10. [Immunochemo-embolization therapy of hepatocellular carcinoma]. Takekoshi H Gan To Kagaku Ryoho; 1991 Aug; 18(11):1916-9. PubMed ID: 1715155 [TBL] [Abstract][Full Text] [Related]
11. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma]. Jin-no K Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695 [TBL] [Abstract][Full Text] [Related]
12. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization. Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Higuchi T; Kikuchi M; Okazaki M Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245 [TBL] [Abstract][Full Text] [Related]
14. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303 [TBL] [Abstract][Full Text] [Related]
15. [Transcatheter arterial embolization of hepatocellular carcinoma using CO2-US]. Miyajima Y; Sakaguchi S; Tohara K Nihon Rinsho; 1998 Apr; 56(4):990-3. PubMed ID: 9577622 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Ohishi H; Uchida H; Yoshimura H; Ohue S; Ueda J; Katsuragi M; Matsuo N; Hosogi Y Radiology; 1985 Jan; 154(1):25-9. PubMed ID: 2981114 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma]. Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472 [TBL] [Abstract][Full Text] [Related]
18. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma]. Ihaya T; Ametani M; Matsusue E Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698 [TBL] [Abstract][Full Text] [Related]
19. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429 [TBL] [Abstract][Full Text] [Related]
20. [Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol]. Mlinarić B Lijec Vjesn; 2000; 122(1-2):6-8. PubMed ID: 10916349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]